The event organised by Zoetis (a global animal health company) examined the challenges faced by the animal livestock industry. EPHA attended the meeting to collect and present the key messages of the workshop for EPHA Members.
– the final Zoetis Workshop Summary report
– Sandra Beaty from Zoetis stressed that EU legislation should be based on evidences and science.
– In his presentation Prof. David Leaver, Emeritus Professor
The Royal Agricultural College UK, pointed out that if Europe’s competitiveness in the food market cannot keep up with other region’s, then imports of food from outside will be necessary.
Food security aspects
- European food production is high and production potential is even higher. However, Europe wastes a lot of food.
- The livestock industry contributes to 39% of agriculture outputs (compared with 15 % for the fruit & vegetable industry)
- According to the EU Commission’s estimations, the net trade position of the EU is projected to deteriorate. It will increase meat imports which would result in a parallel decline in exports of poultry (an indicator of declining competitiveness).
- Food, energy and water security are closely linked to climate change – a potentially ‘perfect storm’ for food, energy and water shortages by 2030.
- There is a risk to disease transmission from animals to humans which could lead to epidemics or pandemics
- It is essential that policies within the EU – especially the CAP – have a sustainable intensification of food production as a strategic priority – otherwise food security will be at risk.
– In her presentation Patricia Reilly, Member of Cabinet Máire Geoghegan-Quinn, European Commissioner for Research, Innovation and Science pointed out that:
- Animal disease is a threat to human health
- Zoonoses, influenza, BSE, foodborne pathogens (salmonella, campylobacter, parasites such as trichinella or echinococcus) can be transmitted from animals to humans (they do not necessarily cause serious illness in animals).
- Dealing with animal health challenges might mean indirectly tackling some public health challenges. As prevention is better than cure, some appropriate tools are:
- knowledge of the disease,
- diagnostic tools,
- a network of epidemiosurveillance networks,
- good management practices,
- precision farming,
- breeding (for robustness, resistance),
- nutrition (probiotics, prebiotics),
- vaccines (not for all diseases)
- The risk related to AMR is increasing worldwide.
- The European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) have reported that 25000 patients died in the EU from an infection due to multidrug resistance bacteria.
- Under the Framework programmes (FR) for research, between 1999-2012 appoximately €600 million was spent, mostly on human health.
- There is a need for further analysis of transmission of disease between pets and humans.
- Horizon 2020 focuses on societal challenges EU societies are facing (e.g. health, food security and sustainable agriculture, clean energy and transport). Research will increasingly play a major role in this process to successfully tackling these challenges.
– In his presentation, Scott Brown, Executive Director, Pharmaceutical Discovery, Zoetis Veterinary Medicine Research and Development, said that”:
- Bacteria can be beneficial, neutral, or harmful – there is more bacteria in the colon than cells in the whole human body.
- 64% of the 1400 human pathogens are zoonitic and 12 of the 13 significant human epidemics from 1993 were caused by zoonotics.
- As the food supply has become globalised so has the spread of microbes which is a worrying concern from a public health point of view.
- Animals will continue to get sick, even with optimal use of the tools in the kit
- Antibiotics and vaccines are product categories where constant updates and innovations are vital
- Responsibly developing new antibiotics and alternatives to antimicrobials are important to both human and animal health. The regulatory pathway needs to remain feasible, transparent and science-based.
- Consumers tend to prefer the status quo – anything new is always a matter of concern. Therefore the policymakers’ role is to recognise the need for Research & Development and inform and educate consumers about its importance.
—–
EPHA related articles:
————-
- [->5373]
- [->5501]
- [->5428]
- [->5425]
- [->5559]
- [->5484]
- [->5429]
- [->5378]
- [->5229]
